Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia‑1

Hyun-Ju Yu1, Ji-Ae Shin1, Su-Jung Choi1

  • 1Department of Oral Pathology, School of Dentistry and Dental Research Institute, Seoul National University, Seoul 03080, Republic of Korea.

Insights

Podophyllotoxin (PPT) inhibits oral squamous cell carcinoma (OSCC) growth by inducing apoptosis. This mechanism involves targeting myeloid cell leukemia-1 (Mcl-1) protein degradation, offering a potential therapeutic strategy for OSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Podophyllotoxin (PPT) shows cytotoxicity against cancer cells.
  • The precise mechanism of PPT against oral squamous cell carcinoma (OSCC) remains unclear.

Purpose of the Study:

  • To elucidate the molecular mechanism of PPT-induced cytotoxicity in OSCC.
  • To investigate the role of myeloid cell leukemia-1 (Mcl-1) in PPT's action.

Main Methods:

  • Annexin V/PI staining, Sub-G1 analysis, soft agar assays, Western blotting, qPCR.
  • JC-1 assay and cell fractionation to assess mitochondrial membrane potential.
  • Mcl-1 overexpression cell lines were used to determine Mcl-1's role.

Main Results:

  • PPT inhibited growth and induced apoptosis in OSCC cell lines (HSC3, HSC4).
  • PPT treatment led to mitochondrial membrane depolarization.
  • PPT reduced Mcl-1 expression via proteasome-dependent degradation.

Conclusions:

  • PPT induces apoptosis in OSCC by targeting Mcl-1 protein.
  • This study provides a basis for further pre-clinical and clinical evaluation of PPT for OSCC management.